Oncology Molecular Diagnostics Market to Grow at 6.2% CAGR, Reaching USD 6.46 Billion by 2033, Led by Roche, Abbott, and Qiagen | DataM Intelligence

The global Oncology Molecular Diagnostics Market reached USD 3.79 Billion in 2024 and is projected to reach USD 6.46 Billion by 2033, growing at a CAGR of 6.2% during the forecast period 2025-2033, according to DataM Intelligence.

United States: Recent Industry Developments

✅ In October 2025, Roche Diagnostics launched a comprehensive liquid biopsy panel for early detection of 50 cancer types from a single blood draw.
✅ In October 2025, the FDA approved Foundation Medicine's new companion diagnostic for a novel targeted therapy in lung cancer.
✅ In October 2025, Guardant Health introduced an AI-powered platform for real-time monitoring of treatment response in metastatic cancers.

Japan: Recent Industry Developments

✅ In October 2025, Sysmex Corporation developed a novel circulating tumour DNA detection system with 99% specificity for early cancer screening.
✅ In October 2025, the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) fast-tracked approval for five new companion diagnostics.
✅ In October 2025, Miraca Holdings launched a nationwide molecular profiling program for personalised cancer treatment across 200 hospitals.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/oncology-molecular-diagnostics-market?jd

Market Trends & Drivers

The Oncology Molecular Diagnostics Market is experiencing rapid growth driven by increasing cancer prevalence, advancements in precision medicine, and rising adoption of companion diagnostics. Key trends include the shift towards liquid biopsy technologies, integration of artificial intelligence in data analysis, and development of multi-cancer early detection tests. The growing emphasis on personalized treatment, regulatory support for targeted therapies, and technological innovations in genomic sequencing are significantly accelerating market expansion.

Competitive Landscape

The market features intense competition among diagnostic companies, pharmaceutical partners, and technology innovators.

Roche Diagnostics leads with its cobas portfolio and comprehensive companion diagnostic solutions.
Abbott Laboratories dominates in PCR-based oncology testing and rapid diagnostic platforms.
Qiagen N.V. provides sample preparation technologies and bioinformatics solutions for molecular diagnostics.
Foundation Medicine, Inc. (Roche) specializes in comprehensive genomic profiling for cancer patients.
Guardant Health, Inc. pioneers liquid biopsy technology for cancer detection and monitoring.
Illumina, Inc. provides next-generation sequencing platforms for comprehensive genomic analysis.
Myriad Genetics, Inc. focuses on hereditary cancer testing and companion diagnostics.
Agilent Technologies, Inc. offers advanced instrumentation and reagents for molecular pathology.
Bio-Rad Laboratories, Inc. provides droplet digital PCR technology for sensitive mutation detection.
Thermo Fisher Scientific delivers comprehensive solutions from sample to answer in molecular diagnostics.

Segmentation

By Product Type [Reagents, Instruments, Software]
By Technology [Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), In Situ Hybridization (ISH), Others]
By Application [Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, Others]
By End-User [Hospitals, Clinical Laboratories, Others]

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/oncology-molecular-diagnostics-market?jd

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (Germany, U.K., France, Italy, Spain, Switzerland, Rest of Europe)
⇥ Asia-Pacific (Japan, China, India, South Korea, Australia, Rest of Asia Pacific)
⇥ South America (Brazil, Argentina, Colombia, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?jd

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us:
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us:
DataM Intelligence is a market research and consulting firm that bridges the gap between data and decisive action. We specialise in translating top market trends and in-depth analysis into swift, smart solutions for your business.
With a repository of 6,300+ reports across 40+ industries, we provide the robust intelligence that over 200 companies in 50+ countries rely on to power their growth.

This release was published on openPR.